Back

Use of sacubitril-valsartan in heart failure with reduced ejection fraction: real world experience

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Fernanda Costa Ferreira

CUF Cascais Hospital, Cascais (Portugal)

55 More presentations in this session

Presentation thumbnail
Doctor A. Ntalianis (Athens, GR)
Abstract
Presentation thumbnail
Doctor J. AGOSTINHO (Lisbon, PT)
Abstract
Presentation thumbnail
Ms E. O'Donoghue (Dublin, IE)
Abstract
Presentation thumbnail
Doctor V. Gomez Leiva (San Salvador, SV)
Abstract Slides
Presentation thumbnail
Doctor F. Batar (Sibiu, RO)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Sacubitril/Valsartan efficacy on functional, laboratory, echocardiographic parameters: a real-world study
29 June 2021
thumbnail
Congress Session
Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation
18 May 2025
thumbnail
Congress Presentation
Real-world off-label Sacubitril/Valsartan dosing and clinical outcomes in patients with heart failure and end-stage kidney disease
31 August 2026
thumbnail
Congress Presentation
SGLT2i in heart failure with reduced ejection fraction: benefits in real life?
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources